Invention Grant
US07902201B2 Isoxazolo-pyrazine derivatives 有权
异恶唑并吡嗪衍生物

Isoxazolo-pyrazine derivatives
Abstract:
The invention relates to isoxazolo-pyrazine derivatives and their pharmaceutically acceptable salts having affinity and selectivity for the GABA A α5 receptor binding site, their manufacture, and pharmaceutical compositions containing them. The compounds of the present invention are inverse agonists of GABAAα5. The invention also relates to methods for enhancing cognition and for treating cognitive disorders like Alzheimer's disease.
Public/Granted literature
Information query
Patent Agency Ranking
0/0